Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Geriatrics Reports
Published in: Current Geriatrics Reports 3/2013

01-09-2013 | Infectious Diseases in the Elderly (SF Bradley, Section Editor)

Impact and Management of MRSA in the Long-Term Care Setting

Author: Christopher J. Crnich

Published in: Current Geriatrics Reports | Issue 3/2013

Login to get access

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of morbidity and mortality in healthcare facilities. Residents of nursing homes are commonly colonized with MRSA and acquisition within these facilities is common. While treatment of MRSA infection in the NH is more costly than treatment of infections caused by methicillin-susceptible strains, the frequency of serious infections and attributable mortality remains uncommon. Consequently, controlling the spread of MRSA in NHs is primarily a population health concern and interventions to control intrafacility transmissions should be balanced with a concern for resident quality-of-life.
Literature
1.
• Klein E, Smith D, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005. Emerging Infect Dis. 2007;13:1840–6. These three articles nicely summarize patters of infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the United States over the past decade.
2.
• Klevens R, Morrison M, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763–71. These three articles nicely summarize patters of infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the United States over the past decade.
3.
• Elixhauser A, Steiner C. Infections with Methicillin-resistant Staphylococcus Aureus (MRSA) in U.S. Hospitals, 1993–2005. Healthcare Cost and Utilization Project: Statistical Brief #35. Agency for Healthcare Research and Quality. 2007. These three articles nicely summarize patters of infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the United States over the past decade.
4.
Noskin GA, Rubin RJ, Schentag JJ, et al. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998–2003). Clin Infect Dis. 2007;45:1132–40.PubMedCrossRef
5.
Kallen AJ, Mu Y, Bulens S, et al. Health care-associated invasive MRSA infections, 2005–2008. JAMA. 2010;304:641–8.PubMedCrossRef
6.
Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006;34:15–21.PubMedCrossRef
7.
Christensen KLY, Holman RC, Steiner CA, Sejvar JJ, Stoll BJ, Schonberger LB. Infectious disease hospitalizations in the United States. Clin Infect Dis. 2009;49:1025–35.PubMedCrossRef
8.
Fukuta Y, Cunningham CA, Harris PL, Wagener MM, Muder RR. Identifying the Risk Factors for Hospital-Acquired Methicillin-Resistant Staphylococcus aureus (MRSA) Infection among Patients Colonized with MRSA on Admission. Infect Control Hosp Epidemiol. 2012;33:1219–25.PubMedCrossRef
9.
Schoevaerdts D, Agelas J-P, Ingels M-G, et al. Health outcomes of older patients colonized by multi-drug resistant bacteria (MDRB): a one-year follow-up study. Arch Gerontol Geriatr. 2013;56:231–6.PubMedCrossRef
10.
Stone N, Lewis D, Lowery H, et al. Importance of bacterial burden among methicillin-resistant Staphylococcus aureus carriers in a long-term care facility. Infect Control Hosp Epidemiol. 2008;29:143–8.PubMedCrossRef
11.
Furuno JP, Hebden JN, Standiford HC, et al. Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility. Am J Infect Control. 2008;36:468–71.PubMedCrossRef
12.
Reynolds C, Quan V, Kim D, et al. Methicillin-resistant Staphylococcus aureus (MRSA) carriage in 10 nursing homes in Orange County, California. Infect Control Hosp Epidemiol. 2011;32:91–3.PubMedCrossRef
13.
Crnich CJ, Duster M, Hess T, Zimmerman DR, Drinka P. Antibiotic resistance in non-major metropolitan skilled nursing facilities: prevalence and interfacility variation. Infect Control Hosp Epidemiol. 2012;33:1172–4.PubMedCrossRef
14.
Strausbaugh LJ, Jacobson C, Sewell DL, Potter S, Ward TT. Methicillin-resistant Staphylococcus aureus in extended-care facilities: experiences in a Veterans’ Affairs nursing home and a review of the literature. Infect Control Hosp Epidemiol. 1991;12:36–45.PubMedCrossRef
15.
• Muder R, Brennen C, Wagener M, et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med. 1991;114:107–12. These studies are two of the best examinations of the natural history of MRSA in nursing homes with a stable (non-outbreak) prevalence of MRSA.PubMedCrossRef
16.
• Bradley S, Terpenning M, Ramsey M, et al. Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med. 1991;115:417–22. These studies are two of the best examinations of the natural history of MRSA in nursing homes with a stable (non-outbreak) prevalence of MRSA.PubMedCrossRef
17.
Hsu CC. Serial survey of methicillin-resistant Staphylococcus aureus nasal carriage among residents in a nursing home. Infect Control Hosp Epidemiol. 1991;12:416–21.PubMedCrossRef
18.
Mulhausen PL, Harrell LJ, Weinberger M, Kochersberger GG, Feussner JR. Contrasting methicillin-resistant Staphylococcus aureus colonization in Veterans Affairs and community nursing homes. Am J Med. 1996;100:24–31.PubMedCrossRef
19.
• Mody L, Kauffman CA, Donabedian S, Zervos M, Bradley SF. Epidemiology of Staphylococcus aureus colonization in nursing home residents. Clin Infect Dis. 2008;46:1368–73. A good example of the risk factors and different patterns of MRSA colonization of residents in nursing homes.PubMedCrossRef
20.
Manzur A, Gudiol F. Methicillin-resistant Staphylococcus aureus in long-term-care facilities. Clin Microbiol Infect. 2009;15 Suppl 7:26–30.PubMedCrossRef
21.
Storch GA, Radcliff JL, Meyer PL, Hinrichs JH. Methicillin-resistant Staphylococcus aureus in a nursing home. Infect Control. 1987;8:24–9.PubMed
22.
Thomas JC, Bridge J, Waterman S, Vogt J, Kilman L, Hancock G. Transmission and control of methicillin-resistant Staphylococcus aureus in a skilled nursing facility. Infect Control Hosp Epidemiol. 1989;10:106–10.PubMedCrossRef
23.
Trick W, Weinstein R, Demarais P, et al. Comparison of routine glove use and contact-isolation precautions to prevent transmission of multidrug-resistant bacteria in a long-term care facility. J Am Geriatr Soc. 2004;52:2003–9.PubMedCrossRef
24.
• Furuno JP, Shurland SM, Zhan M, et al. Comparison of the Methicillin-Resistant Staphylococcus aureus Acquisition among Rehabilitation and Nursing Home Residents. Infect Control Hosp Epidemiol. 2011;32:244–9. A nicely done study examining differences in risk factors for the acquisition of MRSA among residents on post-acute versus long-term stay unites in three different long-term care facilities.PubMedCrossRef
25.
Fisch J, Lansing B, Wang L, et al. New acquisition of antibiotic-resistant organisms in skilled nursing facilities. J Clin Microbiol. 2012;50:1698–703.PubMedCrossRef
26.
Murphy CR, Quan V, Kim D, et al. Nursing home characteristics associated with methicillin-resistant Staphylococcus aureus (MRSA) Burden and Transmission. BMC Infect Dis. 2012;12:269.PubMedCrossRef
27.
• Stone ND, Lewis DR, Johnson TM, et al. Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Carriage in Residents of Veterans Affairs Long-Term Care Facilities: Role of Antimicrobial Exposure and MRSA Acquisition. Infect Control Hosp Epidemiol. 2012;33:551–7. A well-designed epidemiological study of MRSA acquisition performed in three different long-term care facilities. A major finding of this study was the strong association between recent antibiotic use and acquisition of MRSA.PubMedCrossRef
28.
Elixhauser A, Steiner C. Statistical brief #35: infection with methicillin-resistant Staphylococcus aureus (MRSA) in U.S. hospitals, 1993–2005. 2009;
29.
Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7:629–41.PubMedCrossRef
30.
Klevens R, Edwards J, Richards C, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122:160–6.PubMed
31.
Deleo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet. 2010;375:1557–68.PubMedCrossRef
32.
Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerging Infect Dis. 2007;13:236–42.PubMedCrossRef
33.
Carleton HA, Diep BA, Charlebois ED, Sensabaugh GF, Perdreau-Remington F. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis. 2004;190:1730–8.PubMedCrossRef
34.
Shurland SM, Stine OC, Venezia RA, et al. Colonization sites of USA300 methicillin-resistant Staphylococcus aureus in residents of extended care facilities. Infect Control Hosp Epidemiol. 2009;30:313–8.PubMedCrossRef
35.
Murphy CR, Hudson LO, Spratt BG, et al. Predicting High Prevalence of Community Methicillin-Resistant Staphylococcus aureus Strains in Nursing Homes. Infect Control Hosp Epidemiol. 2013;34:325–6.PubMedCrossRef
36.
Tattevin P, Diep BA, Jula M, Perdreau-Remington F. Methicillin-resistant Staphylococcus aureus USA300 clone in long-term care facility. Emerging Infect Dis. 2009;15:953–5.PubMedCrossRef
37.
Crnich CJ, Duster M, Hess T, Zimmerman DR, Drinka P. Antibiotic resistance in non-major metropolitan nursing homes: prevalence and inter-facility variation. Infect Control Hosp Epidemiol under revision.
38.
Safdar N, Bradley EA. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med. 2008;121:310–5.PubMedCrossRef
39.
Shurland SM, Stine OC, Venezia RA, et al. USA300 methicillin-resistant S. aureus (USA300 MRSA) colonization and the risk of MRSA infection in residents of extended-care facilities. Epidemiol Infect. 2011:1–10.
40.
Bradley EH, Holmboe ES, Mattera JA, Roumanis SA, Radford MJ, Krumholz HM. A qualitative study of increasing beta-blocker use after myocardial infarction: Why do some hospitals succeed? JAMA. 2001;285:2604–11.PubMedCrossRef
41.
Muder R, Brennen C, Goetz A, Wagener M, Rihs J. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center. Antimicrob Agents Chemother. 1991;35:256–8.PubMedCrossRef
42.
Niclaes L, Buntinx F, Banuro F, Lesaffre E, Heyrman J. Consequences of MRSA carriage in nursing home residents. Epidemiol Infect. 1999;122:235–9.PubMedCrossRef
43.
Suetens C, Niclaes L, Jans B, et al. Methicillin-Resistant Staphylococcus aureus Colonization Is Associated with Higher Mortality in Nursing Home Residents with Impaired Cognitive Status. J Am Geriatr Soc. 2006;54:1854–60.PubMedCrossRef
44.
Manzur A, DE Gopegui ER, Dominguez M, et al. Clinical significance of methicillin-resistant Staphylococcus aureus colonization in residents in community long-term-care facilities in Spain. Epidemiol Infect. 2011:1–7.
45.
Capitano B, Leshem O, Nightingale C, Nicolau D. Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facility. J Am Geriatr Soc. 2003;51:10–6.PubMedCrossRef
46.
•• Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18–55. This is an excellent guideline summarizing the antimicrobial and non-antimicrobial management of different types of MRSA infections in both inpatient and outpatient settings. A must read for any clinician.PubMedCrossRef
47.
Jeng A, Beheshti M, Li J, Nathan R. The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. Medicine. 2010;89:217–26.PubMedCrossRef
48.
Fitch MT, Manthey DE, McGinnis HD, Nicks BA, Pariyadath M. Videos in clinical medicine. Abscess incision and drainage. N Engl J Med. 2007;357:e20.PubMedCrossRef
49.
Rajendran PM, Young D, Maurer T, et al. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother. 2007;51:4044–8.PubMedCrossRef
50.
Schmitz GR, Bruner D, Pitotti R, et al. Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. Ann Emerg Med. 2010;56:283–7.PubMedCrossRef
51.
• Livesley NJ, Chow AW. Infected pressure ulcers in elderly individuals. Clin Infect Dis. 2002;35:1390–6. These two guidelines provide an in-depth review of the management of patients with pressure ulcers and diabetic foot ulcers, two conditions that are ubiquitous in the long-term care setting.PubMedCrossRef
52.
• Lipsky BA, Berendt AR, Cornia PB, et al. Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:e132–73. These two guidelines provide an in-depth review of the management of patients with pressure ulcers and diabetic foot ulcers, two conditions that are ubiquitous in the long-term care setting.PubMedCrossRef
53.
Drinka P, Bonham P, Crnich CJ. Swab culture of purulent skin infection to detect infection or colonization with antibiotic-resistant bacteria. J Am Med Dir Assoc. 2012;13:75–9.PubMedCrossRef
54.
Muder RR, Brennen C, Rihs JD, et al. Isolation of Staphylococcus aureus from the urinary tract: association of isolation with symptomatic urinary tract infection and subsequent staphylococcal bacteremia. Clin Infect Dis. 2006;42:46–50.PubMedCrossRef
55.
• Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625–63. An exhaustively referenced evidence-based document on the management and prevention of urinary tract infections in adult patients, both those with and without indwelling urinary catheters.PubMedCrossRef
56.
Raz R, Schiller D, Nicolle LE. Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J Urol. 2000;164:1254–8.PubMedCrossRef
57.
Gould FK, Brindle R, Chadwick PR, et al. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. J Antimicrob Chemother. 2009;63:849–61.PubMedCrossRef
58.
Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128:3854–62.PubMedCrossRef
59.
Drinka P, Niederman MS, El-Solh AA, Crnich CJ. Assessment of risk factors for multi-drug resistant organisms to guide empiric antibiotic selection in long term care: a dilemma. J Am Med Dir Assoc. 2011;12:321–5.PubMedCrossRef
60.
El-Solh AA, Akinnusi ME, Alfarah Z, Patel A. Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home-acquired pneumonia. J Am Geriatr Soc. 2009;57:1030–5.PubMedCrossRef
61.
Brito V, Niederman MS. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis. 2009;22:316–25.PubMedCrossRef
62.
• Crnich CJ, Drinka P. Medical device-associated infections in the long-term care setting. Infect Dis Clin North Am. 2012;26:143–64. A nice review of the presentation and management of different types of device-related infections encountered in nursing homes.PubMedCrossRef
63.
Datta R, Huang SS. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis. 2008;47:176–81.PubMedCrossRef
64.
Mody L, Bradley SF, Galecki A, et al. Conceptual model for reducing infections and antimicrobial resistance in skilled nursing facilities: focusing on residents with indwelling devices. Clin Infect Dis. 2011;52:654–61.PubMedCrossRef
65.
Bode LGM, Kluytmans JAJW, Wertheim HFL, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362:9–17.PubMedCrossRef
66.
Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D’Agata EMC. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis. 2003;37:1629–38.PubMedCrossRef
67.
Strausbaugh LJ, Jacobson C, Sewell DL, Potter S, Ward TT. Antimicrobial therapy for methicillin-resistant Staphylococcus aureus colonization in residents and staff of a Veterans Affairs nursing home care unit. Infect Control Hosp Epidemiol. 1992;13:151–9.PubMedCrossRef
68.
Cederna JE, Terpenning MS, Ensberg M, Bradley SF, Kauffman CA. Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin. Infect Control Hosp Epidemiol. 1990;11:13–6.PubMedCrossRef
69.
Kauffman CA, Terpenning MS, He X, et al. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment. Am J Med. 1993;94:371–8.PubMedCrossRef
70.
Mody L, Kauffman CA, McNeil SA, Galecki AT, Bradley SF. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003;37:1467–74.PubMedCrossRef
71.
Simor AE, Augustin A, Ng J, Betschel S, McArthur M. Control of MRSA in a long-term care facility. Infect Control Hosp Epidemiol. 1994;15:69–70.PubMedCrossRef
72.
Kotilainen P, Routamaa M, Peltonen R, et al. Eradication of methicillin-resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med. 2001;161:859–63.PubMedCrossRef
73.
Harberg D. Society for Healthcare Epidemiology of America guideline approach works to control a methicillin-resistant Staphylococcus aureus outbreak. Infect Control Hosp Epidemiol. 2005;26:115–6.PubMedCrossRef
74.
Bowler WA, Bresnahan J, Bradfish A, Fernandez C. An integrated approach to methicillin-resistant Staphylococcus aureus control in a rural, regional-referral healthcare setting. Infect Control Hosp Epidemiol. 2010;31:269–75.PubMedCrossRef
75.
Cooper B, Stone S, Kibbler C, et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ. 2004;329:533–40.PubMedCrossRef
76.
Bradley SF. Eradication or decolonization of methicillin-resistant Staphylococcus aureus carriage: what are we doing and why are we doing it? Clin Infect Dis. 2007;44:186–9.PubMedCrossRef
77.
Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003;24:362–86.PubMedCrossRef
78.
Siegel JD, Rhinehart E, Jackson M, Chiarello L. Healthcare Infection Control Practices Advisory C. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35:S165–93.PubMedCrossRef
79.
Calfee DP, Salgado CD, Classen D, et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29:S62–80.PubMedCrossRef
80.
• Rebmann T, Aureden K. Association for Professionals in Infection Control and Epidemiology. Preventing methicillin-resistant Staphylococcus aureus transmission in long-term care facilities: an executive summary of the APIC Elimination Guide. Am J Infect Control. 2011;39:235–8. Both of these references address issues of controlling the spread of MRSA in nursing homes and are an attempt to different from hospitals. While the recommendations have not been validated empirically, they are thoughtful reviews on the unique challenges that providers face in nursing homes.
81.
• Cahill CK. Joint infection prevention and control guidelines: enhanced standard precautions (ESP) for California long-term care facilities. 2010. Available at: http://​www.​cdph.​ca.​gov/​programs/​hai/​Documents/​AFL10-27AttachmentIncl​uded.​pdf. Accessed 8 April 2013. Both of these references address issues of controlling the spread of MRSA in nursing homes and are an attempt to different from hospitals. While the recommendations have not been validated empirically, they are thoughtful reviews on the unique challenges that providers face in nursing homes.
82.
Hughes C, Smith M, Tunney M, Bradley MC. Infection control strategies for preventing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in nursing homes for older people. Cochrane Database Syst Rev. 2011;12, CD006354.PubMed
83.
• Bradley SF. Methicillin-resistant Staphylococcus aureus: long-term care concerns. Am J Med. 1999;106:2S–10. discussion 48S–52S. A nice review on the issues germane to the control of MRSA in nursing homes. The author provides a nice conceptual overview that is somewhat different than the one proposed in this review.PubMedCrossRef
84.
Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet. 2000;356:1307–12.PubMedCrossRef
85.
Baldwin NS, Gilpin DF, Tunney MM, et al. Cluster randomised controlled trial of an infection control education and training intervention programme focusing on meticillin-resistant Staphylococcus aureus in nursing homes for older people. J Hosp Infect. 2010;76:36–41.PubMedCrossRef
86.
Chami K, Gavazzi G, Bar-Hen A, et al. A short-term, multicomponent infection control program in nursing homes: a cluster randomized controlled trial. J Am Med Dir Assoc. 2012;13:569.e9–17.CrossRef
87.
Horner C, Wilcox M, Barr B, et al. The longitudinal prevalence of MRSA in care home residents and the effectiveness of improving infection prevention knowledge and practice on colonisation using a stepped wedge study design. BMJ Open. 2012;2:e000423.PubMedCrossRef
88.
Wenzel RP, Bearman G, Edmond MB. Screening for MRSA: a flawed hospital infection control intervention. Infect Control Hosp Epidemiol. 2008;29:1012–8.PubMedCrossRef
89.
Wenzel RP, Edmond MB. Infection control: the case for horizontal rather than vertical interventional programs. Int J Infect Dis. 2010;14 Suppl 4:S3–5.PubMedCrossRef
90.
Lee BY, Singh A, Bartsch SM, et al. The Potential Regional Impact of Contact Precaution Use in Nursing Homes to Control Methicillin-Resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2013;34:151–60.PubMedCrossRef
91.
Crnich CJ, Drinka PJ. Predicting the impact of contact precautions on MRSA outcomes: caution up ahead. Infect Control Hosp Epidemiol. 2013;(in press).
92.
Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with Contact Precautions: a review of the literature. Am J Infect Control. 2009;37:85–93.PubMedCrossRef
93.
Day HR, Perencevich EN, Harris AD, et al. Do contact precautions cause depression? A two-year study at a tertiary care medical centre. J Hosp Infect. 2011;79:103–7.PubMedCrossRef
94.
Morgan DJ, Pineles L, Shardell M, et al. The effect of contact precautions on healthcare worker activity in acute care hospitals. Infect Control Hosp Epidemiol. 2013;34:69–73.PubMedCrossRef
95.
Office of Veteran Affairs. Guidelines for implementation of MRSA Prevention Initiative in the Community Living Centers (CLC). Veterans Health Administration. 2008.
96.
Bryce EA, Tiffin SM, Isaac-Renton JL, Wright CJ. Evidence of delays in transferring patients with methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus to long-term-care facilities. Infect Control Hosp Epidemiol. 2000;21:270–1.PubMedCrossRef
97.
Kreman T, Hu J, Pottinger J, Herwaldt LA. Survey of long-term-care facilities in Iowa for policies and practices regarding residents with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 2005;26:811–5.PubMedCrossRef
98.
Robicsek A, Beaumont JL, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med. 2008;148:409–18.PubMedCrossRef
99.
Vos MC, Behrendt MD, Melles DC, et al. 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands. Infect Control Hosp Epidemiol. 2009;30:977–84.PubMedCrossRef
100.
Jain R, Kralovic SM, Evans ME, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med. 2011;364:1419–30.PubMedCrossRef
101.
Datta R, Platt R, Yokoe DS, Huang SS. Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants. Arch Intern Med. 2011;171:491–4.PubMedCrossRef
102.
Murphy CR, Eells SJ, Quan V, et al. Methicillin-resistant Staphylococcus aureus burden in nursing homes associated with environmental contamination of common areas. J Am Geriatr Soc. 2012;60:1012–8.PubMedCrossRef
103.
Nicolle L, Bentley D, Garibaldi R, Neuhaus E, Smith P. Antimicrobial use in long-term-care facilities. Infect Control Hosp Epidemiol. 2000;21:537–45.PubMedCrossRef
104.
Smith D, Dushoff J, Perencevich E, Harris A, Levin S. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci USA. 2004;101:3709–14.PubMedCrossRef
105.
Lee BY, Bartsch SM, Wong KF, et al. The importance of Nursing Homes in the spread of Methicillin-resistant Staphylococcus aureus (MRSA) among hospitals. Med Care. 2013;
106.
Spindel SJ, Strausbaugh LJ, Jacobson C. Infections caused by Staphylococcus aureus in a Veterans’ Affairs nursing home care unit: a 5-year experience. Infect Control Hosp Epidemiol. 1995;16:217–23.PubMedCrossRef
107.
Lee YL, Cesario T, Gupta G, et al. Surveillance of colonization and infection with Staphylococcus aureus susceptible or resistant to methicillin in a community skilled-nursing facility. Am J Infect Control. 1997;25:312–21.PubMedCrossRef
Metadata
Title
Impact and Management of MRSA in the Long-Term Care Setting
Author
Christopher J. Crnich
Publication date
01-09-2013
Publisher
Springer US
Published in
Current Geriatrics Reports / Issue 3/2013
Electronic ISSN: 2196-7865
DOI
https://doi.org/10.1007/s13670-013-0047-4

Other articles of this Issue 3/2013

Current Geriatrics Reports 3/2013 Go to the issue

Infectious Diseases in the Elderly (SF Bradley, Section Editor)

Issues Surrounding Antibiotic Use in Older Adults

Neurology of Aging (KS Marder, Section Editor)

Relationship of Gait and Cognition in the Elderly

NEUROLOGY OF AGING (K MARDER, SECTION EDITOR)

Treatment of Alzheimer’s Disease: Current Management and Experimental Therapeutics

Neurology of Aging (KS Marder, Section Editor)

Vascular Dementia

Infectious Diseases in the Elderly (SF Bradley, Section Editor)

Changing Epidemiology and Control of Clostridium difficile in Older Adults

Infectious Diseases in the Elderly (SF Bradley, Section Editor)

The Epidemiology and Clinical Impact of Surgical Site Infections in the Older Adult
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits